Insider Transactions in Q1 2021 at Icu Medical Inc (ICUI)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Robert S Swinney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.88%
|
$66,000
$44.82 P/Share
|
|
Mar 06
2021
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,599
-21.13%
|
-
|
|
Mar 06
2021
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,039
+28.63%
|
-
|
|
Mar 06
2021
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,267
-7.56%
|
-
|
|
Mar 06
2021
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,862
+14.58%
|
-
|
|
Mar 06
2021
|
Kevin J Mc Grody Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,351
-12.63%
|
-
|
|
Mar 06
2021
|
Kevin J Mc Grody Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,568
+19.33%
|
-
|
|
Mar 06
2021
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,194
-6.59%
|
-
|
|
Mar 06
2021
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,168
+11.12%
|
-
|
|
Mar 06
2021
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,103
-7.93%
|
-
|
|
Mar 06
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,897
+12.99%
|
-
|
|
Mar 06
2021
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-19.17%
|
-
|
|
Mar 06
2021
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,272
+26.51%
|
-
|
|
Mar 02
2021
|
Robert S Swinney Director |
SELL
Open market or private sale
|
Direct |
1,500
-6.25%
|
$310,500
$207.0 P/Share
|
|
Feb 18
2021
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
554
-22.14%
|
-
|
|
Feb 18
2021
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,005
+28.66%
|
-
|
|
Feb 18
2021
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
377
-5.43%
|
-
|
|
Feb 18
2021
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
804
+10.38%
|
-
|
|
Feb 18
2021
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,235
-29.65%
|
-
|
|
Feb 18
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,044
+36.02%
|
-
|
|
Feb 18
2021
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,873
-17.11%
|
-
|
|
Feb 18
2021
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,519
+24.32%
|
-
|
|
Feb 02
2021
|
Robert S Swinney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.88%
|
$64,500
$43.12 P/Share
|
|
Jan 08
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
38,591
-36.81%
|
$8,490,020
$220.0 P/Share
|
|
Jan 08
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
38,591
+26.91%
|
$2,238,278
$58.79 P/Share
|
|
Jan 07
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
6,070
-8.39%
|
$1,335,400
$220.0 P/Share
|
|
Jan 07
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,070
+7.74%
|
$352,060
$58.79 P/Share
|
|
Jan 06
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
24,339
-26.87%
|
$5,354,580
$220.0 P/Share
|
|
Jan 06
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,339
+12.59%
|
$1,411,662
$58.79 P/Share
|
|
Jan 04
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,500
-1.96%
|
$2,438,000
$212.87 P/Share
|
|
Jan 04
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+12.89%
|
$667,000
$58.79 P/Share
|